Opportunity
Simpler Grants.gov #PAR-27-082
NIAID Investigator-Initiated Program Project (P01) Research Grants for Infectious Diseases and Immunology
Buyer
National Institutes of Health
Posted
May 07, 2026
Respond By
May 25, 2029
Identifier
PAR-27-082
NAICS
541715, 541714
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), is seeking investigator-initiated Program Project (P01) applications to advance research in infectious diseases and immunology. - Government Buyer: - National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) - Scope of Opportunity: - Solicits research proposals in areas such as: - Biology and pathogenesis of infectious microbes (e.g., HIV) - Host-microbe interactions - Immune system development, function, and dysfunction (including allergy, asthma, autoimmunity, immunodeficiency, and transplant rejection) - Translational research for vaccines, therapeutics, and diagnostics - Application Requirements: - Must include at least two synergistic research projects with a common central theme - Must include an Administrative Core - May include Scientific Core(s) if needed - Eligibility: - Open to U.S. government entities, educational institutions, businesses, and nonprofits - Foreign organizations are not eligible - No OEMs, vendors, or specific products/services are mentioned, as this is a research grant opportunity, not a procurement of goods or services.
Description
This notice of funding opportunity invites submission of investigator-initiated Program Project (P01) applications addressing scientific areas relevant to the NIAID mission, including infectious microbes, immune system mechanisms, immune dysfunction, and translational research for vaccines and therapeutics. Each application must include at least two related, synergistic Research Projects sharing a common theme and an Administrative Core, with optional Scientific Core(s). Eligible applicants include various government entities, educational institutions, businesses, nonprofits, and others, excluding foreign organizations. The funding instrument is a grant with no cost sharing required.